The policies and procedures developed by The Biomarkers Consortium are intended to outline general principles to facilitate the use of data and technologies in expanded biomarker research and development efforts conducted by the Biomarkers Consortium while ensuring compliance with relevant requirements of antitrust and other federal law.

The policies and procedures established by The Biomarkers Consortium include:

For more information about the policies and procedures of The Consortium, please contact us at biomarkers@fnih.org.

Front Page: